Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Razia Adam Kadwa

Razia Adam Kadwa

Ankura Hospital for Women and Children, India.

Title: Novel mutation of ATP6V1A gene associated with Infantile spasms and Microcephaly

Biography

Biography: Razia Adam Kadwa

Abstract

We describe a seven-month-old boy who presented with flexor spasms of two weeks duration. He was first born child to unrelated parents. Term delivery with uneventful pregnancy and normal development milestones till seven-months of age. On examination he had small head with closed anterior fontanels. EEG was suggestive of hypsarrythmia with multifocal inter ictal discharges.

Etiologic investigations: Magnetic resonance imaging (MRI), chemical and physical examination of cerebrospinal fluid, pyruvic acid and lactic acid on plasma and cerebrospinal fluid, plasma and urinary aminoacids, urinary organic acids, CSF glycine and aminoacids , biotinidase levels were normal. Exome sequencing of a multigene epilepsy panel for EIEE detected ATP6VA1 mutation.

Child was treated with ACTH with complete cessation of spasms however he had recurrence after five months of stopping steroids. Currently he is on multiple anti epileptic drugs with partial response. Four cases with ATP6V1A mutations have been reported till date, all of them had preexisting developmental delay and fever associated seizures, followed by epileptic encephalopathy. This child was developmentally normal and there were no episodes of fever triggered seizures. He presented with infantile spasms and neuroregression followed by refractory seizures. This is the first case report of ATP6V1A mutation presenting as infantile spasms and refractory Epilepsy in a developmentally normal child. The present case adds to the few cases of epileptic encephalopathies so far reported that were caused by ATP6V1A gene mutations and expands the clinical spectrum of ATP6V1A mutation associated epilepsy.